Pathogenesis (disease development) It is not exactly clear which causes are responsible for the development of breast carcinoma. In most cases, the disease occurs spontaneously.Even more than for the familial forms of breast carcinoma, genetic defects are responsible for the spontaneous development of this carcinoma. In 40 percent of patients with breast carcinoma, a p53 … Breast Cancer (Mammary Carcinoma): Causes
Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used to prevent (prevent) breast cancer. Folic acid Vitamin D Lutein, lycopene, zeaxanthin In the context of micronutrient medicine (vital substances), the following vital substances (macro- and micronutrients) are used for supportive therapy. Gamma-linolenic acid (GLA) Case reports continue to report … Breast Cancer (Mammary Carcinoma): Micronutrient Therapy
General With few exceptions (e.g., high-risk patients with a family history who may have preventive surgery), breast cancer therapy today consists of a combination of different therapies (surgery, radiotherapy (radiation therapy), chemotherapy, antihormone therapy). Preoperative imaging, punch or vacuum biopsy diagnostics in combination with: Histology (fine tissue examination), Grading (assessment of the degree of differentiation … Breast Cancer (Mammary Carcinoma): Surgical Therapy
Primary prevention For primary prevention of breast carcinoma, attention must be paid to reducing individual risk factors. Familial breast and ovarian cancer (ovarian cancer). Women with a high risk of developing breast carcinoma have: Mutations in the BRCA1-, BRCA2- RAD 51 C-, and D- genes (the latter are not routinely determined), Women at >20% risk … Breast Cancer (Mammary Carcinoma): Prevention